{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:35:34Z","timestamp":1790933734610,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2006,1,1]]},"DOI":"10.1532\/ijh97.a30505","type":"journal-article","created":{"date-parts":[[2006,1,26]],"date-time":"2006-01-26T19:39:10Z","timestamp":1138304350000},"page":"66-73","source":"Crossref","is-referenced-by-count":32,"title":["Adoptive Transfer of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocytes for the Treatment of Angiocentric Lymphomas"],"prefix":"10.1007","volume":"83","author":[{"given":"Hyun-Il","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Choo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-Gyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"E00001","first-page":"467","author":"Fechner, RE","year":"1972","unstructured":"Fechner RE, Lampin DW. Midline malignant reticulosis. Arch Oto-laryngol. 1972;95:467-476.","journal-title":"Arch Oto-laryngol"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/07357908409040316","author":"Jaffe, ES","year":"1984","unstructured":"Jaffe ES. Pathologic and clinical spectrum of post-thymic T-cell malignancies. Cancer Invest. 1984;2:413-426.","journal-title":"Cancer Invest"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood.V72.5.1674.1674","author":"Lipford, EH","year":"1988","unstructured":"Lipford EH, Margolick JB, Longo DL, Fauci AS, Jaffe ES. Angio-centric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferation. Blood. 1988;72:1674-1681.","journal-title":"Blood"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/0046-8177(91)90269-U","author":"Medeiros, LJ","year":"1991","unstructured":"Medeiros LJ, Peiper SC, Elwood L, Yano T, Raffeld M, Jaffe ES. Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. Hum Pathol. 1991;22:1150-1157.","journal-title":"Hum Pathol"},{"key":"E00005","first-page":"271","author":"Ho, FC","year":"1990","unstructured":"Ho FC, Srivastava G, Loke SL, et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol. 1990;8:271-281.","journal-title":"Hematol Oncol"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1099-1069(199705)15:2<71::AID-HON601>3.0.CO;2-U","author":"Kwong, YL","year":"1997","unstructured":"Kwong YL, Chan AC, Liang RH. Natural killer cell lymphoma\/ leukemia: pathology and treatment. Hematol Oncol. 1997;15:71-79.","journal-title":"Hematol Oncol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hon.2900100303","author":"Aviles, A","year":"1992","unstructured":"Aviles A, Rodriguez L, Guzman R, Talavera A, Garcia EL, Diaz-Maquero JC. Angiocentric T-cell lymphoma of the nose, paranasal sinuses and hard palate. Hematol Oncol. 1992;10:141-147.","journal-title":"Hematol Oncol"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00000478-199103000-00007","author":"Ferry, JA","year":"1991","unstructured":"Ferry JA, Sklar J, Zukerberg LR, Harris NL. Nasal lymphoma: a clinicopathologic study with immunophenotypic and genotypic analysis. Am J Surg Pathol. 1991;15:268-279.","journal-title":"Am J Surg Pathol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-199601000-00012","author":"Jaffe, ES","year":"1996","unstructured":"Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T\/Natural Killer Cell Lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.","journal-title":"Am J Surg Pathol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2000.18.1.54","author":"Kim, GE","year":"2000","unstructured":"Kim GE, Cho JH, Yang WI, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol. 2000;18:54-63.","journal-title":"J Clin Oncol"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<806::AID-CNCR26>3.0.CO;2-V","author":"Ko, YH","year":"1998","unstructured":"Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hema-tolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer. 1998;83: 806-812.","journal-title":"Cancer"},{"key":"E00012","first-page":"297","author":"Raab-Traub, N","year":"1992","unstructured":"Raab-Traub N. Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol. 1992;3:297-307.","journal-title":"Semin Cancer Biol"},{"key":"E00013","first-page":"285","author":"Magrath, I","year":"1992","unstructured":"Magrath I, Jain V, Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol. 1992;3:285-295.","journal-title":"Semin Cancer Biol"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0065-230X(08)61003-9","author":"Thomas, JA","year":"1991","unstructured":"Thomas JA, Allday MJ, Crawford DH. Epstein-Barr virus-associated lymphoproliferative disorders in immunocompromised individuals. Adv Cancer Res. 1991;57:329-380.","journal-title":"Adv Cancer Res"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","author":"Rooney, CM","year":"1995","unstructured":"Rooney CM, Smith CA, Ng CY, et al. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lym-phoproliferation. Lancet. 1995;345:9-13.","journal-title":"Lancet"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","author":"Heslop, HE","year":"1996","unstructured":"Heslop HE, Ng CY, Li C, et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat Med. 1996;2:551-555.","journal-title":"Nat Med"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-065X.1997.tb00984.x","author":"Heslop, HE","year":"1997","unstructured":"Heslop HE, Rooney CM. Adoptive cellular immunotherapy for EBV lymphoproliferative disease. Immunol Rev. 1997;157:217-222.","journal-title":"Immunol Rev"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","author":"Rooney, CM","year":"1998","unstructured":"Rooney CM, Smith CA, Ng CY, et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 1998;92: 1549-1555.","journal-title":"Blood"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","author":"Rooney, CM","year":"1998","unstructured":"Rooney CM, Roskrow MA, Suzuki N, Ng CY, Brenner MK, Hes-lop H.Treatment of relapsed Hodgkin's disease using EBV-specific cytotoxic T cells. Ann Oncol. 1998;9:S129-S132.","journal-title":"Blood"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934","author":"Roskrow, MA","year":"1998","unstructured":"Roskrow MA, Suzuki N, Gan Y, et al. Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood. 1998;91: 2925-2934.","journal-title":"Blood"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.1430","author":"Chua, D","year":"2001","unstructured":"Chua D, Huang J, Zheng B, et al. Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma. Int J Cancer. 2001;94:73-80.","journal-title":"Int J Cancer"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.1430","author":"Chua, D","year":"2001","unstructured":"Comoli P, De Palma R, Siena S, et al. Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma. Ann Oncol. 2004;15:113-117.","journal-title":"Int J Cancer"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ijc.1430","author":"Chua, D","year":"2001","unstructured":"Lucas KG, Salzman D, Garcia A, et al. Adoptive immunotherapy with allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease. Cancer 2004;100:1892-1901.","journal-title":"Int J Cancer"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-07-2975","author":"Straathof, KC","year":"2005","unstructured":"Straathof KC, Bollard CM, Popat U, et al. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood. 2005;105:1898-1904.","journal-title":"Blood"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1399-0039.1994.tb02372.x","author":"Sadler, AM","year":"1994","unstructured":"Sadler AM, Petronzelli F, Krausa P, et al. Low-resolution DNA typing for HLA-B using sequence-specific primers in allele- or group-specific ARMS\/PCR. Tissue Antigens. 1994;44:148-154.","journal-title":"Tissue Antigens"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0268-960X(90)90012-H","author":"Tiercy, JM","year":"1990","unstructured":"Tiercy JM, Jeannet M, Mach B. A new approach for the analysis of HLA class II polymorphism: 'HLA oligotyping.' Blood Rev. 1990; 4:9-15.","journal-title":"' Blood Rev"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0264-410X(03)00569-3","author":"Cho, HI","year":"2003","unstructured":"Cho HI, Kim HJ, Oh ST, Kim TG. In vitro induction of carcinoem-bryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses. Vaccine. 2003;22:224-236.","journal-title":"Vaccine"},{"key":"E00028","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0264-410X(03)00569-3","author":"Cho, HI","year":"2003","unstructured":"Cuadra-Garcia I, Proulx GM, Wu CL, et al. Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol. 1999;23:1356-1369.","journal-title":"Vaccine"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0264-410X(03)00569-3","author":"Cho, HI","year":"2003","unstructured":"Kwong YL, Chan AC, Liang R, et al. CD56 NK lymphomas: clinicopathological features and prognosis. Br J Haematol. 1997;97: 821-829.","journal-title":"Vaccine"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bmt.1700606","author":"Liang, R","year":"1997","unstructured":"Liang R, Chen F, Lee CK, et al. Autologous bone marrow transplantation for primary nasal T\/NK cell lymphoma. Bone Marrow Transplant. 1997;19:91-93.","journal-title":"Bone Marrow Transplant"},{"key":"E00031","first-page":"171","author":"McKinnon, KP","year":"1998","unstructured":"Wheatley GH 3rd, McKinnon KP, Iacobucci M, Mahon S, Gelber C, Lyerly HK. Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of post-transplantation lymphoma. Surgery. 1998;124:171-176.","journal-title":"Surgery"},{"key":"E00032","first-page":"171","author":"McKinnon, KP","year":"1998","unstructured":"Albert ML, Pearce SF, Francisco LM, et al. Immature dendritic cells phagocytose apoptotic cells via 33 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med. 1998;188: 1359-1368.","journal-title":"Surgery"},{"key":"E00033","first-page":"171","author":"McKinnon, KP","year":"1998","unstructured":"Subklewe M, Paludan C, Tsang ML, Mahnke K, Steinman RM, Munz C. Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8 killer T cells. J Exp Med. 2001;193:405-411.","journal-title":"Surgery"},{"key":"E00034","first-page":"171","author":"McKinnon, KP","year":"1998","unstructured":"Gahn B, Siller-Lopez F, Pirooz AD, et al. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma. Int J Cancer. 2001;93:706-713.","journal-title":"Surgery"},{"key":"E00035","first-page":"171","author":"McKinnon, KP","year":"1998","unstructured":"Gottschalk S, Edwards OL, Sili U, et al. Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Blood. 2003; 101:1905-1912.","journal-title":"Surgery"},{"key":"E00036","first-page":"171","author":"McKinnon, KP","year":"1998","unstructured":"Bollard CM, Straathof KC, Huls MH, et al. The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease. J Immunother. 2004;27:317-327.","journal-title":"Surgery"},{"key":"E00037","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-8140(01)00428-5","author":"Kim, GE","year":"2001","unstructured":"Kim GE, Lee SW, Chang SK, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol. 2001;61:261-269.","journal-title":"Radiother Oncol"},{"key":"E00038","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.bmt.1701803","author":"Nawa, Y","year":"1999","unstructured":"Nawa Y, Takenaka K, Shinagawa K, et al. Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;23:1321-1322.","journal-title":"Bone Marrow Transplant"},{"key":"E00039","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.bmt.1701803","author":"Nawa, Y","year":"1999","unstructured":"Takenaka K, Shinagawa K, Maeda Y, et al. High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56 natural killer cell lymphomas. Leuk Lymphoma. 2001;42:1297-1303.","journal-title":"Bone Marrow Transplant"},{"key":"E00040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bmt.1703796","author":"Okamura, T","year":"2003","unstructured":"Okamura T, Kishimoto T, Inoue M, et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T\/NK-cell lym-phoproliferative disease. Bone Marrow Transplant. 2003;31: 105-111.","journal-title":"Bone Marrow Transplant"},{"key":"E00041","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V86.4.1493.bloodjournal8641493","author":"Frisan, T","year":"1995","unstructured":"Frisan T, Sjoberg J, Dolcetti R, et al. Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood. 1995;86:1493-1501.","journal-title":"Blood"},{"key":"E00042","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V89.6.1978","author":"Sing, AP","year":"1997","unstructured":"Sing AP, Ambinder RF, Hong DJ, et al. Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: implications for immune-mediated therapy of EBV Hodgkin's disease. Blood. 1997;89:1978-1986.","journal-title":"Blood"},{"key":"E00043","first-page":"6219","author":"Chapman, AL","year":"2001","unstructured":"Chapman AL, Rickinson AB, Thomas WA, Jarrett RF, Crocker J, Lee SP. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res. 2001; 61:6219-6226.","journal-title":"Cancer Res"},{"key":"E00044","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","author":"Haque, T","year":"2002","unstructured":"Haque T, Wilkie GM, Taylor C, et al. Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet. 2002;360:436-442.","journal-title":"Lancet"},{"key":"E00045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","author":"Trinchieri, G","year":"1989","unstructured":"Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47: 187-376.","journal-title":"Adv Immunol"},{"key":"E00046","first-page":"267","author":"Tay, CH","year":"1997","unstructured":"Tay CH, Welsh RM. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol. 1997;71:267-275.","journal-title":"J Virol"},{"key":"E00047","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJM198906293202605","author":"Biron, CA","year":"1989","unstructured":"Biron CA, Byron KS, Sullivan JL. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med. 1989;320: 1731-1735.","journal-title":"N Engl J Med"},{"key":"E00048","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nrc928","author":"Smyth, MJ","year":"2002","unstructured":"Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002;2:850-861.","journal-title":"Nat Rev Cancer"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.A30505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T10:26:56Z","timestamp":1586687216000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.A30505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1,1]]}},"alternative-id":["986U63PDGL4GE93X"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.a30505","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1,1]]}}}